China has exhibited one of the most transformational evolutions ever seen in emerging markets (EMs), with its weight in the MSCI EM Index doubling over the past five years. But China’s own dynamic and mega-cap stocks have somehow skewed EM benchmarks’ performance. We believe that beyond China, EMs offer an attractive and differentiated opportunity set—one which drove our launch of our EM ex China Growth strategy. In this Q&A, Romina Graiver, partner, a portfolio specialist on our global equity team, discusses the opportunity set and process driving our strategy.
